Article(id=1329914508778255187, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914419489911429, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.04.010, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1698249600000, receivedDateStr=2023-10-26, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005927509, onlineDateStr=2026-11-18, pubDate=1712678400000, pubDateStr=2024-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005927509, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005927509, creator=13701087609, updateTime=1795005927509, updator=13701087609, issue=Issue{id=1329914419489911429, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='4', pageStart='445', pageEnd='591', issueExtLink='null', onlineDate='null', pubDate='1712678400000', pubDateStr='2024-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005906221, creator='13701087609', updateTime=1795136111536, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460540603839226, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914419489911429, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460540603839227, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914419489911429, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=510, endPage=514, ext={EN=ArticleExt(id=1329914508983776084, articleId=1329914508778255187, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Synthetic Process Improvement of Zolpidem Tartrate, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

An improved synthetic process of zolpidem tartrate(1) was developed. Glyoxylic acid(4)was reacted with acetic anhydride to obtain 2,2-diacetoxyacetic acid(5), which was chlorinated by thionyl chloride to generate 2,2-diacetoxyacetyl chloride(6). Then, 6 reacted with dimethylamine chloride to provide N,N-dimethyl-2,2-diacetoxyacetamide(7). Finally, 7 was hydrolyzed by pyridinium 4-toluenesulfonate to afford the key intermediate N,N-dimethyl-2-oxoacetamide(8). p-Methylacetophenone(2) was another starting material, and brominated with bromine, followed by the reaction with 2-amino-5-methylpyridine by “one-pot” method to synthesize 6-methyl-2-(4-methylphenyl)-imidazole[1,2-a]pyridine (3), which was converted into α-hydroxyzolpidem(9) via nucleophilic addition with 8, and then 9 was subjected to the reduction by chlorotrimethylsilane/NaI system to bring out zolpidem(10). Finally, the target compound 1 was obtained from 10 through salification with L-(+)-tartaric acid with an overall yield of 52.4%(based on 2)and the purity of 99.89%. The process was stable with simple operation and low cost, which was suitable for industrial production.

, authors=Guanglong BAO1, 2, Naihua ZHANG1, 2, Qingtao CHEN1, 2, Zhong FENG1, 2, *, Guimin ZHANG1, 2, *, authorsList=Guanglong BAO, Naihua ZHANG, Qingtao CHEN, Zhong FENG, Guimin ZHANG, authorCompany=null, correspAuthors=Zhong FENG, Guimin ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914509281571669, articleId=1329914508778255187, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=酒石酸唑吡坦的合成工艺优化, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

文章对酒石酸唑吡坦(1)的合成工艺进行了改进与优化。以乙醛酸(4)为起始原料与乙酸酐反应得到2,2-二乙酰氧基乙酸(5),5经氯化亚砜氯代生成2,2-二乙酰氧基乙酰氯(6),然后6与二甲胺反应制得N,N-二甲基-2,2-二乙酰氧基乙酰胺(7),7经吡啶对甲苯磺酸盐水解得关键侧链中间体N,N-二甲基-2-氧代乙酰胺(8)。以对甲基苯乙酮(2)为另一起始物料,经溴素溴代后与2-氨基-5-甲基吡啶经“一锅法”合成6-甲基-2-(4-甲基苯基)咪唑[1,2-a]吡啶(3),然后3与8亲核加成制得α-羟基唑吡坦(9),9经三甲基氯硅烷/碘化钠体系一步还原生成唑吡坦(10),最后10与L-(+)-酒石酸成盐制得1,纯度>99.89%,总收率52.4%(以2计)。改进后的工艺稳定、操作简便、生产成本低,适合工业化生产。

, authors=鲍广龙1, 2, 张乃华1, 2, 陈庆涛1, 2, 冯中1, 2, *, 张贵民1, 2, *, authorsList=鲍广龙, 张乃华, 陈庆涛, 冯中, 张贵民, authorCompany=null, correspAuthors=冯中, 张贵民, authorNote=

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

, correspAuthorsNote=
冯中(1983—),男,正高级工程师,从事药物研究与开发。E-mail:
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=YMpxb14Gs8s3UQYDc+BUpA==, magXml=Jv1kVFk4RkPFo8CljzjHKA==, pdfUrl=null, pdf=9almJi6E0w1imo5TNKgsfg==, pdfFileSize=2079053, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=A6T1gpctJZ4kI/Xydoedcw==, mapNumber=null, fund=null)}, authors=[Author(id=1329915015177547812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329915015282405415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015177547812, language=EN, stringName=Guanglong BAO, firstName=Guanglong, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915015353708584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015177547812, language=CN, stringName=鲍广龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio={"content":"

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

"}, bioImg=null, bioContent=

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915015416623146, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329915015492120621, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015416623146, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915015555035182, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015416623146, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915015622144048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329915015722807347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015622144048, language=EN, stringName=Qingtao CHEN, firstName=Qingtao, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915015789916212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015622144048, language=CN, stringName=陈庆涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915015873802294, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=fengzhong22@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329915015961882681, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015873802294, language=EN, stringName=Zhong FENG, firstName=Zhong, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915016054157370, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015873802294, language=CN, stringName=冯中, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915016117071932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329915016209346623, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915016117071932, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915016268066880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915016117071932, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])])], keywords=[Keyword(id=1329915016398090305, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=EN, orderNo=1, keyword=zolpidem tartrate), Keyword(id=1329915016461004866, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=EN, orderNo=2, keyword=sedative-hypnotics), Keyword(id=1329915016528113731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=EN, orderNo=3, keyword=synthetic process), Keyword(id=1329915016591028292, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=EN, orderNo=4, keyword=pharmaceutical process), Keyword(id=1329915016658137157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=CN, orderNo=1, keyword=酒石酸唑吡坦), Keyword(id=1329915016708468806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=CN, orderNo=2, keyword=镇静催眠药), Keyword(id=1329915016758800455, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=CN, orderNo=3, keyword=合成工艺), Keyword(id=1329915016813326408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, language=CN, orderNo=4, keyword=制药工艺)], refs=[Reference(id=1329915017081761866, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=黄薛冰,杨德森.新一代镇静催眠药唑吡坦[J].临床精神医学杂志,2000,10(4):253-254., articleTitle=null, refAbstract=null), Reference(id=1329915017144676427, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=廖凡,关禹,黄文武,等.酒石酸唑吡坦的绿色合成工艺研究[J].中国药物化学杂志,2018,28(2):39-42., articleTitle=null, refAbstract=null), Reference(id=1329915017211785292, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ALLEN J, TIZOT A.Synthesis of [14C]zolpidem [J].J Labelled Compd Rad, 1986, 23(4): 393-400., articleTitle=null, refAbstract=null), Reference(id=1329915017270505549, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=CHINNAPILLAI R, NALLAMADDI R R, ARAVA V R,et al.Process for preparing zolpidem and its intermediate: WO, 2009007995A1[P].2009-01-15., articleTitle=null, refAbstract=null), Reference(id=1329915017333420110, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH A A, DHALE A D.Zolpidem, method of preparation and an intermediate therein: WO, 2015011722A2[P].2015-01-29., articleTitle=null, refAbstract=null), Reference(id=1329915017434083407, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=KAPLAN J P, GEORGE P, BERNARDON J M.Therapeutically useful imidazo[l,2-a]pyridine derivatives: US, 4492695A [P].1985-01-08., articleTitle=null, refAbstract=null), Reference(id=1329915017501192272, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LABRIOLA R.Process for preparing N,N,6-trimethyl-2-(4-methylphenyl)-imidazo-[1,2-a]-pyridine -3-acetamide and salts thereof: WO, 0008021A2 [P].2000-02-17., articleTitle=null, refAbstract=null), Reference(id=1329915017572495441, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=埃吉斯药物工厂.制备6-甲基-2-(4-甲基-苯基)-咪唑并[1,2-a]嘧啶-3-N,N-二甲基-乙酰胺)和中间体的方法:中国,1413212A [P].2003-04-23., articleTitle=null, refAbstract=null), Reference(id=1329915017631215698, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=STEPHEN P F, ROBERT I M, PHILIP A L, et al.Immunoassay with extended detection window: US, 20110189794Al [P].2011-08-04., articleTitle=null, refAbstract=null), Reference(id=1329915017698324563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ETTEMA G J B, LEMMENS J M, PETERS T H A, et al.Imidazopyridine derivatives and process for making them: EP, 1038875A2 [P].1999-10-22., articleTitle=null, refAbstract=null), Reference(id=1329915017761239124, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=REY M, RÖSSLER A, DERUNGS G, et al.Process for the preparation of imidazopyridines: WO, 0214306A1 [P].2002-02-21., articleTitle=null, refAbstract=null), Reference(id=1329915017840930901, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SAKHARDANDE R, SANTOSH C, CHAUDHARI H, et al.Process for the preparation of imidazopyridines: EP, 1917263B1 [P].2005-02-12., articleTitle=null, refAbstract=null), Reference(id=1329915017916428374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=YATENDRA K, MOHAN P, AZOK N.Synthesis of N,N-dimethyl-3-(4-methyl)benzoyl propionamide a key intermediate of zolpidem: US, 20040054230Al [P].2004-03-18., articleTitle=null, refAbstract=null), Reference(id=1329915017975148631, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAZIANO C.Process for the preparation of 2-phenyl-imidazo[1,2-a]pyridine-3-acetamides: US, 6384226B2 [P].2002-05-07., articleTitle=null, refAbstract=null), Reference(id=1329915018042257496, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=MARKUS S, WOLFGANG W.Process for preparing zolpidem: US, 6664421B2 [P].2003-12-16., articleTitle=null, refAbstract=null), Reference(id=1329915018105172057, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=赵建宏,关禹,廖凡,等.酒石酸唑吡坦的合成新工艺[J].中国医药工业杂志,2017,48(12):1726-1730., articleTitle=null, refAbstract=null), Reference(id=1329915018163892314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=台湾神隆股份有限公司.咪唑并[1,2-a]吡啶-3-乙酰胺类的制备方法:中国,1668617A [P].2005-09-14., articleTitle=null, refAbstract=null), Reference(id=1329915018243584091, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=吉锁兴.酒石酸唑吡坦的合成[J].中国药业,2014,23(5):16-17., articleTitle=null, refAbstract=null), Reference(id=1329915018314887260, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=雷新胜,林国强,许千千,等.一种制备化合物唑吡坦的方法:中国,103360387A [P].2013-10-23., articleTitle=null, refAbstract=null), Reference(id=1329915018373607517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=TATIANA B, IRINA M, DARIA T, et al.A novel formulation of zolpidem for direct nose-to-brain delivery: synthesis, encapsulation and intranasal administration to mice [J].J Pharm Pharmacol, 2018, 79(9): 1164-1173., articleTitle=null, refAbstract=null), Reference(id=1329915018449104990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ABBINENI J B, KONUDULA B R, GADUPUDI S B, et al.Improved process for the preparation of 6-methyl-2-[4-methyl phenyl]imidazo[1,2-a]pyridine-3-N,N-dimethyl acetamide: WO, 2010122576A1 [P].2010-10-28., articleTitle=null, refAbstract=null), Reference(id=1329915018512019551, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=GUY R, DAYID L.Process for the preparation of imidazopyridines: US, 4794185A [P].1988-12-27., articleTitle=null, refAbstract=null), Reference(id=1329915018583322720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=REWCASTLE G W, SUTHERLAND H S, WEIR C A, et al.An improved synthesis of isonitrosoacetanilides [J].Tetrahedron Lett, 2005, 46(50): 8719-8721., articleTitle=null, refAbstract=null), Reference(id=1329915018646237281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=于成彬,商素珍.一种唑吡坦中间体N,N-二甲基-2-氧乙酰胺的制备方法:中国,114249668A [P].2022-03-29., articleTitle=null, refAbstract=null), Reference(id=1329915018717540450, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=PRATAP R P, SATYANARAYANA B, ANANDA M J, et al.Process for preparing zolpidem: US, 20070027180A1 [P].2007-02-01., articleTitle=null, refAbstract=null), Reference(id=1329915018788843619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=周竞成.酒石酸唑吡坦的合成工艺研究[J].天津药学,2002,14(1):69-70., articleTitle=null, refAbstract=null), Reference(id=1329915018855952484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=马林克罗特公司.杂芳基乙酰胺的合成:中国,1729188A [P].2003-12-16., articleTitle=null, refAbstract=null), Reference(id=1329915018918867045, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=马林克罗特公司.由具有减少的水含量的反应混合物合成杂芳基乙酰胺:中国,1972939A [P].2005-06-03., articleTitle=null, refAbstract=null), Reference(id=1329915018977587302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=PASCAL G, JOHN A.Imidopyridines useful in therapy: US, 4808594A [P].1989-02-28., articleTitle=null, refAbstract=null), Reference(id=1329915019040501863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CAIN G A, HOLLER E R.Extended scope of in situ iodotrimethylsilane mediated selective reduction of benzylic alcohols [J].Chem Commun, 2001, (13): 1168-1169., articleTitle=null, refAbstract=null), Reference(id=1329915019103416424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=张贵民,于成彬,段良兴.一种唑吡坦中间体的制备方法:中国,a)114249724A [P].2022-03-29; b)114249724B [P].2023-05-26., articleTitle=null, refAbstract=null), Reference(id=1329915019170525289, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=BARTH W E.6-(1-Carbamoyl-1-hydroxymethyl)penicillanic acid derivatives: US, 4797394A [P].1989-01-10., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329915016955932745, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, awardId=tscx202306086, language=CN, fundingSource=泰山产业创新领军人才项目(tscx202306086), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.04.010, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.04.010, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.04.010, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.04.010, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1712678400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
酒石酸唑吡坦的合成工艺优化
鲍广龙 1, 2 , 张乃华 1, 2 , 陈庆涛 1, 2 , 冯中 1, 2, * , 张贵民 1, 2, *
中国医药工业杂志 | 研究论文 2024,55(4): 510-514
收起
收藏切换
中国医药工业杂志 |研究论文 2024 , 55 (4) : 510 -514
酒石酸唑吡坦的合成工艺优化
全屏
[Author(id=1329915015177547812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329915015282405415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015177547812, language=EN, stringName=Guanglong BAO, firstName=Guanglong, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915015353708584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015177547812, language=CN, stringName=鲍广龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio={"content":"

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

"}, bioImg=null, bioContent=

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915015416623146, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329915015492120621, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015416623146, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915015555035182, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015416623146, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915015622144048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329915015722807347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015622144048, language=EN, stringName=Qingtao CHEN, firstName=Qingtao, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915015789916212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015622144048, language=CN, stringName=陈庆涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915015873802294, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=fengzhong22@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329915015961882681, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015873802294, language=EN, stringName=Zhong FENG, firstName=Zhong, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915016054157370, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915015873802294, language=CN, stringName=冯中, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])]), Author(id=1329915016117071932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329915016209346623, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915016117071932, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329915016268066880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, authorId=1329915016117071932, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329915015018164253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=1., ext=[AuthorCompanyExt(id=1329915015026552862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015034941471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015018164253, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400)]), AuthorCompany(id=1329915015097856032, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, xref=2., ext=[AuthorCompanyExt(id=1329915015106244641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329915015114633250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914508778255187, companyId=1329915015097856032, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400)])])]
鲍广龙1, 2, 张乃华1, 2, 陈庆涛1, 2, 冯中1, 2, * , 张贵民1, 2, *
作者信息
  • 1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
  • 2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400
通讯作者:
冯中(1983—),男,正高级工程师,从事药物研究与开发。E-mail:
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
作者简介:

鲍广龙(1990—),男,硕士,工程师,从事仿制药物研究。

Synthetic Process Improvement of Zolpidem Tartrate
Guanglong BAO1, 2, Naihua ZHANG1, 2, Qingtao CHEN1, 2, Zhong FENG1, 2, * , Guimin ZHANG1, 2, *
Affiliations
  • 1.Shandong Engineering Research Center for New Drug Pharmaceuticals R&D in Shandong Province, Lunan Better Pharmaceutical Co., Ltd., Linyi 273400
  • 2.Shandong Pharmaceutical Internationalization Engineering Laboratory, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
出版时间: 2024-04-10 doi: 10.16522/j.cnki.cjph.2024.04.010
文章导航
收藏切换

文章对酒石酸唑吡坦(1)的合成工艺进行了改进与优化。以乙醛酸(4)为起始原料与乙酸酐反应得到2,2-二乙酰氧基乙酸(5),5经氯化亚砜氯代生成2,2-二乙酰氧基乙酰氯(6),然后6与二甲胺反应制得N,N-二甲基-2,2-二乙酰氧基乙酰胺(7),7经吡啶对甲苯磺酸盐水解得关键侧链中间体N,N-二甲基-2-氧代乙酰胺(8)。以对甲基苯乙酮(2)为另一起始物料,经溴素溴代后与2-氨基-5-甲基吡啶经“一锅法”合成6-甲基-2-(4-甲基苯基)咪唑[1,2-a]吡啶(3),然后3与8亲核加成制得α-羟基唑吡坦(9),9经三甲基氯硅烷/碘化钠体系一步还原生成唑吡坦(10),最后10与L-(+)-酒石酸成盐制得1,纯度>99.89%,总收率52.4%(以2计)。改进后的工艺稳定、操作简便、生产成本低,适合工业化生产。

酒石酸唑吡坦  /  镇静催眠药  /  合成工艺  /  制药工艺

An improved synthetic process of zolpidem tartrate(1) was developed. Glyoxylic acid(4)was reacted with acetic anhydride to obtain 2,2-diacetoxyacetic acid(5), which was chlorinated by thionyl chloride to generate 2,2-diacetoxyacetyl chloride(6). Then, 6 reacted with dimethylamine chloride to provide N,N-dimethyl-2,2-diacetoxyacetamide(7). Finally, 7 was hydrolyzed by pyridinium 4-toluenesulfonate to afford the key intermediate N,N-dimethyl-2-oxoacetamide(8). p-Methylacetophenone(2) was another starting material, and brominated with bromine, followed by the reaction with 2-amino-5-methylpyridine by “one-pot” method to synthesize 6-methyl-2-(4-methylphenyl)-imidazole[1,2-a]pyridine (3), which was converted into α-hydroxyzolpidem(9) via nucleophilic addition with 8, and then 9 was subjected to the reduction by chlorotrimethylsilane/NaI system to bring out zolpidem(10). Finally, the target compound 1 was obtained from 10 through salification with L-(+)-tartaric acid with an overall yield of 52.4%(based on 2)and the purity of 99.89%. The process was stable with simple operation and low cost, which was suitable for industrial production.

zolpidem tartrate  /  sedative-hypnotics  /  synthetic process  /  pharmaceutical process
鲍广龙, 张乃华, 陈庆涛, 冯中, 张贵民. 酒石酸唑吡坦的合成工艺优化. 中国医药工业杂志, 2024 , 55 (4) : 510 -514 . DOI: 10.16522/j.cnki.cjph.2024.04.010
Guanglong BAO, Naihua ZHANG, Qingtao CHEN, Zhong FENG, Guimin ZHANG. Synthetic Process Improvement of Zolpidem Tartrate[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (4) : 510 -514 . DOI: 10.16522/j.cnki.cjph.2024.04.010
  • 泰山产业创新领军人才项目(tscx202306086)
参考文献 引证文献
排序方式:
[1]
黄薛冰,杨德森.新一代镇静催眠药唑吡坦[J].临床精神医学杂志,2000,10(4):253-254.
[2]
廖凡,关禹,黄文武,等.酒石酸唑吡坦的绿色合成工艺研究[J].中国药物化学杂志,2018,28(2):39-42.
[3]
ALLEN J, TIZOT A.Synthesis of [14C]zolpidem [J].J Labelled Compd Rad, 1986, 23(4): 393-400.
[4]
CHINNAPILLAI R, NALLAMADDI R R, ARAVA V R,et al.Process for preparing zolpidem and its intermediate: WO, 2009007995A1[P].2009-01-15.
[5]
SINGH A A, DHALE A D.Zolpidem, method of preparation and an intermediate therein: WO, 2015011722A2[P].2015-01-29.
[6]
KAPLAN J P, GEORGE P, BERNARDON J M.Therapeutically useful imidazo[l,2-a]pyridine derivatives: US, 4492695A [P].1985-01-08.
[7]
LABRIOLA R.Process for preparing N,N,6-trimethyl-2-(4-methylphenyl)-imidazo-[1,2-a]-pyridine -3-acetamide and salts thereof: WO, 0008021A2 [P].2000-02-17.
[8]
埃吉斯药物工厂.制备6-甲基-2-(4-甲基-苯基)-咪唑并[1,2-a]嘧啶-3-N,N-二甲基-乙酰胺)和中间体的方法:中国,1413212A [P].2003-04-23.
[9]
STEPHEN P F, ROBERT I M, PHILIP A L, et al.Immunoassay with extended detection window: US, 20110189794Al [P].2011-08-04.
[10]
ETTEMA G J B, LEMMENS J M, PETERS T H A, et al.Imidazopyridine derivatives and process for making them: EP, 1038875A2 [P].1999-10-22.
[11]
REY M, RÖSSLER A, DERUNGS G, et al.Process for the preparation of imidazopyridines: WO, 0214306A1 [P].2002-02-21.
[12]
SAKHARDANDE R, SANTOSH C, CHAUDHARI H, et al.Process for the preparation of imidazopyridines: EP, 1917263B1 [P].2005-02-12.
[13]
YATENDRA K, MOHAN P, AZOK N.Synthesis of N,N-dimethyl-3-(4-methyl)benzoyl propionamide a key intermediate of zolpidem: US, 20040054230Al [P].2004-03-18.
[14]
GRAZIANO C.Process for the preparation of 2-phenyl-imidazo[1,2-a]pyridine-3-acetamides: US, 6384226B2 [P].2002-05-07.
[15]
MARKUS S, WOLFGANG W.Process for preparing zolpidem: US, 6664421B2 [P].2003-12-16.
[16]
赵建宏,关禹,廖凡,等.酒石酸唑吡坦的合成新工艺[J].中国医药工业杂志,2017,48(12):1726-1730.
[17]
台湾神隆股份有限公司.咪唑并[1,2-a]吡啶-3-乙酰胺类的制备方法:中国,1668617A [P].2005-09-14.
[18]
吉锁兴.酒石酸唑吡坦的合成[J].中国药业,2014,23(5):16-17.
[19]
雷新胜,林国强,许千千,等.一种制备化合物唑吡坦的方法:中国,103360387A [P].2013-10-23.
[20]
TATIANA B, IRINA M, DARIA T, et al.A novel formulation of zolpidem for direct nose-to-brain delivery: synthesis, encapsulation and intranasal administration to mice [J].J Pharm Pharmacol, 2018, 79(9): 1164-1173.
[21]
ABBINENI J B, KONUDULA B R, GADUPUDI S B, et al.Improved process for the preparation of 6-methyl-2-[4-methyl phenyl]imidazo[1,2-a]pyridine-3-N,N-dimethyl acetamide: WO, 2010122576A1 [P].2010-10-28.
[22]
GUY R, DAYID L.Process for the preparation of imidazopyridines: US, 4794185A [P].1988-12-27.
[23]
REWCASTLE G W, SUTHERLAND H S, WEIR C A, et al.An improved synthesis of isonitrosoacetanilides [J].Tetrahedron Lett, 2005, 46(50): 8719-8721.
[24]
于成彬,商素珍.一种唑吡坦中间体N,N-二甲基-2-氧乙酰胺的制备方法:中国,114249668A [P].2022-03-29.
[25]
PRATAP R P, SATYANARAYANA B, ANANDA M J, et al.Process for preparing zolpidem: US, 20070027180A1 [P].2007-02-01.
[26]
周竞成.酒石酸唑吡坦的合成工艺研究[J].天津药学,2002,14(1):69-70.
[27]
马林克罗特公司.杂芳基乙酰胺的合成:中国,1729188A [P].2003-12-16.
[28]
马林克罗特公司.由具有减少的水含量的反应混合物合成杂芳基乙酰胺:中国,1972939A [P].2005-06-03.
[29]
PASCAL G, JOHN A.Imidopyridines useful in therapy: US, 4808594A [P].1989-02-28.
[30]
CAIN G A, HOLLER E R.Extended scope of in situ iodotrimethylsilane mediated selective reduction of benzylic alcohols [J].Chem Commun, 2001, (13): 1168-1169.
[31]
张贵民,于成彬,段良兴.一种唑吡坦中间体的制备方法:中国,a)114249724A [P].2022-03-29; b)114249724B [P].2023-05-26.
[32]
BARTH W E.6-(1-Carbamoyl-1-hydroxymethyl)penicillanic acid derivatives: US, 4797394A [P].1989-01-10.
2024年第55卷第4期
26
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.04.010
  • 接收时间:2023-10-26
  • 首发时间:2026-11-18
  • 出版时间:2024-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-10-26
基金
泰山产业创新领军人才项目(tscx202306086)
作者信息
    1.鲁南贝特制药有限公司,药物新制剂研发山东省工程研究中心,山东 临沂 273400
    2.山东新时代药业有限公司,山东省药物国际化工程实验室,山东 临沂 273400

通讯作者:

冯中(1983—),男,正高级工程师,从事药物研究与开发。E-mail:
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.04.010
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏